Last10K.com

Alder Biopharmaceuticals Inc (ALDR) SEC Filing 8-K Material Event for the period ending Tuesday, October 23, 2018

Alder Biopharmaceuticals Inc

CIK: 1423824 Ticker: ALDR

View differences made from one to another to evaluate Alder Biopharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Alder Biopharmaceuticals Inc.

Continue

Assess how Alder Biopharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Alder Biopharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ALDR
CIK: 1423824
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-306370
Submitted to the SEC: Wed Oct 24 2018 4:05:35 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Tuesday, October 23, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aldr/0001193125-18-306370.htm